How to Handle Benign Optic Glioma of Childhood: A Short Overview

REFERENCES

• Liu G T. Optic gliomas of the anterior visual pathway. Curr Opin Ophthalmol Oct, 2006; 17(5)427–31
   PubMed Web of Science ®Google Scholar
• Dutton J J. Optic nerve gliomas and meningiomas. Neurol Clin Feb, 1991; 9(1)163–77
   Google Scholar
• Listernick R, Ferner R E, Liu G T, Gutmann D H. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol Mar, 2007; 61(3)189–98
   PubMed Web of Science ®Google Scholar
• Tumialan L M, Dhall S S, Biousse V, Newman N J. Optic nerve glioma and optic neuritis mimicking one another: case report. Neurosurgery Jul, 2005; 57(1)E190, discussion E190
   Google Scholar
• Moradi P, Robson A G, Rose G E, Holder G E. Electrophysiological monitoring in a patient with an optic nerve glioma. Doc Ophthalmol 2008; 117(2)171–4
   Google Scholar
• Trisciuzzi M TS, Riccardi R, Piccardi M, Iarossi G, Buzzonetti L, Dickmann A, Colosimo C, Ruggiero A, Di Rocco C, Falsini B. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol 2004; 115(1)217–26
   Google Scholar
• Wolsey D H, Larson S A, Creel D, Hoffman R. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?. J AAPOS Aug, 2006; 10(4)307–11
   PubMed Web of Science ®Google Scholar
• Balcer L J, Liu G T, Heller G, Bilaniuk L, Volpe N J, Galetta S L, Molloy P T, Phillips P C, Janss A J, Vaughn S, Maguire M. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol Apr, 2001; 131(4)442–5
   Google Scholar
• Alvord E C, Jr., Lofton S. Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. J Neurosurg Jan, 1988; 68(1)85–98
   Google Scholar
• Opocher E, Kremer L C, Da Dalt L, van de Wetering M D, Viscardi E, Caron H N, Perilongo G. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer Aug, 2006; 42(12)1807–16
   PubMed Web of Science ®Google Scholar
• Parsa C F, Givrad S. Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas. Br J Ophthalmol 2008; 92(1)40–6
   PubMed Web of Science ®Google Scholar
• Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg Aug, 2003; 17(4)327–35
   Web of Science ®Google Scholar
• Kaufman L M, Doroftei O. Optic glioma warranting treatment in children. Eye Oct, 2006; 20(10)1149–64
   PubMedGoogle Scholar
• Tong Z, Wanibuchi M, Uede T, Tanabe S, Hashi K. Significant improvement of visual functions after removal of an intracranial giant optic nerve glioma revealing exophytic growth: case report. Neurosurgery 2006; 58(4)E792, discussion E792
   Google Scholar
• North American Study Group for Optic Glioma. Tumor spread in unilateral optic glioma. Neurofibromatosis 1989; 2(4)195–203, Study report No. 2
   Google Scholar
• Fouladi M, Wallace D, Langston J W, Mulhern R, Rose S R, Gajjar A, Sanford R A, Merchant T E, Jenkins J J, Kun L E, Heideman R L. Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer Feb 15, 2003; 97(4)1084–92
   Google Scholar
• Kortmann R-D, Timmermann B, Taylor R E, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow A K, Dieckmann K, Kay S, Bamberg M. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy. Strahlenther Onkol 2003; 179(8)509–20
   Google Scholar
• Kortmann R-D, Timmermann B, Taylor R E, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow A K, Dieckmann K, Kay S, Bamberg M. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity. Strahlenther Onkol 2003; 179(9)585–97
   Google Scholar
• Combs S E, Schulz-Ertner D, Moschos D, Thilmann C, Huber P E, Debus J. Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys 2005; 62(3)814–9
   Google Scholar
• Debus J, Kocagoncu K O, Hoss A, Wenz F, Wannenmacher M. Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int J Radiat Oncol Biol Phys 1999; 44(2)243–8
   Google Scholar
• Saran F H, Baumert B G, Khoo V S, Adams E J, Garre M L, Warrington A P, Brada M. Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. Int J Radiat Oncol Biol Phys 2002; 53(1)43–51
   Google Scholar
• Anderson N E. Late complications in childhood central nervous system tumour survivors. Curr Opin Neurol 2003; 16(6)677–83
   PubMed Web of Science ®Google Scholar
• Mulhern R K, Merchant T E, Gajjar A, Reddick W E, Kun L E. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5(7)399–408
   PubMed Web of Science ®Google Scholar
• Packer R J, Gurney J G, Punyko J A, Donaldson S S, Inskip P D, Stovall M, Yasui Y, Mertens A C, Sklar C A, Nicholson H S, Zeltzer L K, Neglia J P, Robison L L. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 2003; 21(17)3255–61
   PubMed Web of Science ®Google Scholar
• Beyer R A, Paden P, Sobel D F, Flynn F G. Moyamoya pattern of vascular occlusion after radiotherapy for glioma of the optic chiasm. Neurology 1986; 36(9)1173–8
   Google Scholar
• Kestle J R, Hoffman H J, Mock A R. Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 1993; 79(1)32–35
   Google Scholar
• Sharif S, Ferner R, Birch J M, Gillespie J E, Gattamaneni H R, Baser M E, Evans D G. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol Jun 1, 2006; 24(16)2570–5
   PubMed Web of Science ®Google Scholar
• Ullrich N J, Robertson R, Kinnamon D D, Scott R M, Kieran M W, Turner C D, Chi S N, Goumnerova L, Proctor M, Tarbell N J, Marcus K J, Pomeroy S L. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007; 68(12)932–8
   PubMed Web of Science ®Google Scholar
• Lau N, Feldkamp M M, Roncari L, Loehr A H, Shannon P, Gutmann D H, Guha A. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol 2000; 59(9)759–67
   PubMedGoogle Scholar
• Gnekow A K, Kortmann R-D, Pietsch T, Emser A. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy—report from the multicenter treatment study for children and adolescents with a low grade glioma—HIT-LGG 1996—of the Society of Pediatric Oncology and Hematology (GPOH). Klin Padiatr 2004; 216(6)331–42
   PubMed Web of Science ®Google Scholar
• Grill J, Bhangoo R. Recent development in chemotherapy of paediatric brain tumours. Curr Opin Oncol 2007; 19(6)612–5
   Google Scholar
• Mahoney D H, Jr, Cohen M E, Friedman H S, Kepner J L, Gemer L, Langston J W, James H E, Duffner P K, Kun L E. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro Oncol 2000; 2(4)213–20
   Google Scholar
• Moghrabi A, Friedman H S, Ashley D M, Bottom K S, Kerby T, Stewart E, Bruggers C, Provenzale J M, Champagne M, Hershon L, Watral M, Ryan J, Rasheed K, Lovell S, Korones D, Fuchs H, George T, McLendon R E, Friedman A H, Buckley E, Longee D C. Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas. Neurosurg Focus 1998; 4(4)e3
   Google Scholar
• Silva M M, Goldman S, Keating G, Marymont M A, Kalapurakal J, Tomita T. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg 2000; 33(3)151–8
   Google Scholar
• Listernick R, Ferner R E, Liu G T, Gutmann D H. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007; 61(3)189–98
   PubMed Web of Science ®Google Scholar
• Hwang J-M, Cheon J-E, Wang K-C. Visual prognosis of optic glioma. Childs Nerv Syst 2008; 24(6)693–8
   Google Scholar
• Lama G, Esposito Salsano M, Grassia C, Calabrese E, Grassia M G, Bismuto R, Melone M A, Russo S, Scuotto A. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up. Minerva Pediatr Feb, 2007; 59(1)13–21
   PubMedGoogle Scholar
• Parsa C F, Hoyt C S, Lesser R L, Weinstein J M, Strother C M, Muci-Mendoza R, Ramella M, Manor R S, Fletcher W A, Repka M X, Garrity J A, Ebner R N, Monteiro M L, McFadzean R M, Rubtsova I V, Hoyt W F. Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol 2001; 119(4)516–29
   PubMedGoogle Scholar
• Piccirilli M, Lenzi J, Delfinis C, Trasimeni G, Salvati M, Raco A. Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature. Childs Nerv Syst 2006; 22(10)1332–7
   PubMed Web of Science ®Google Scholar
• Pytel P. Spectrum of pediatric gliomas: implications for the development of future therapies. Expert Rev Anticancer Ther 2007; 7(12 Suppl)S51–60
   Google Scholar